Factors That Influence the Virological Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon and Ribavirin
, , , , , , , oraz | 20 kwi 2017
O artykule
Data publikacji: 20 kwi 2017
Zakres stron: 25 - 33
DOI: https://doi.org/10.1515/prilozi-2017-0003
Słowa kluczowe
© 2017
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Beti Todorovska
University Clinic of Gastroenterohepatology, Faculty of Medicine, University “Ss. Cyril and Methodius”, Skopje, Macedonia (the former Yugoslav Republic of)
Nenad Joksimovic
University Clinic of Gastroenterohepatology, Faculty of Medicine, University “Ss. Cyril and Methodius”, Skopje, Macedonia (the former Yugoslav Republic of)
Viktorija Caloska-Ivanova
University Clinic of Gastroenterohepatology, Faculty of Medicine, University “Ss. Cyril and Methodius”, Skopje, Mecedonia (the former Yugoslav Republic of)
Magdalena Dimitrova-Genadieva
University Clinic of Gastroenterohepatology, Faculty of Medicine, University “Ss. Cyril and Methodius”, Skopje, Macedonia (the former Yugoslav Republic of)
Meri Trajkovska
University Clinic of Gastroenterohepatology, Faculty of Medicine, University “Ss. Cyril and Methodius”, Skopje, Macedonia (the former Yugoslav Republic of)
Elena Curakova
University Clinic of Gastroenterohepatology, Faculty of Medicine, University “Ss. Cyril and Methodius”, Skopje, Macedonia (the former Yugoslav Republic of)
Sanja Kiprijanovska
Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, Macedonian Academy of Sciences and Arts, Skopje, Macedonia (the former Yugoslav Republic of)
Beti Zafirova-Ivanovska
Institute of Epidemiology and Biostatistics, Faculty of Medicine, University “Ss. Cyril and Methodius”, Skopje, Macedonia (the former Yugoslav Republic of)
Vladimir Serafimoski
Macedonian Academy of Sciences and Arts, Skopje, Macedonia (the former Yoguslav Repyblic of)